Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
PAR-25-170This grant opportunity is designed to fund projects that develop and test digital health technology (DHT) biomarkers or clinical outcome assessments (COAs) for use in remote monitoring during clinical trials. Applicants should focus on three or more diseases or conditions and include input from patients and advocacy groups. The funding will cover both the technical evaluation of these tools an…
There is a high unmet need for clinical endpoints that can be assessed remotely in clinical trials. As defined in the FDA/NIH’s Biomarkers, EndpointS, and other Tools (BEST) resource, an endpoint is “a precisely defined variable intended to reflect an outcome of interest that is statistically an…
Funding Source
Eligibility
Non-domestic (non-U.S.) Entities (Foreign Organizations) are NOT eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are NOT eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed within applications from eligible U.S. organizati…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers